DEFINITIVE HEALTHCARE CORP. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.3 USD | +2.91% |
|
-4.33% | -46.68% |
| 28/05 | Definitive Healthcare Hires Kevin Coop as CEO | MT |
| 24/05 | Definitive Healthcare Corp. Announces Appointment of Kevin Coop as Member of the Board, Effective June 24, 2024 | CI |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 2,713 | 1,155 | 1,156 | 625.1 | - | - |
| Enterprise Value (EV) 1 | 2,596 | 1,087 | 1,105 | 569.8 | 517.3 | 480.8 |
| P/E ratio | -144 x | -183 x | -5.55 x | -19.1 x | -20.9 x | -13.9 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 16.3 x | 5.19 x | 4.6 x | 2.42 x | 2.29 x | 2.14 x |
| EV / Revenue | 15.6 x | 4.88 x | 4.39 x | 2.21 x | 1.89 x | 1.64 x |
| EV / EBITDA | 46.4 x | 17.1 x | 14.8 x | 6.89 x | 5.66 x | 4.62 x |
| EV / FCF | 140 x | 39.9 x | 28.9 x | 8.02 x | 6.12 x | 4.62 x |
| FCF Yield | 0.71% | 2.51% | 3.46% | 12.5% | 16.3% | 21.6% |
| Price to Book | 4.77 x | 1.8 x | 1.3 x | 0.78 x | 0.85 x | 0.84 x |
| Nbr of stocks (in thousands) | 99,263 | 1,05,080 | 1,16,328 | 1,17,935 | - | - |
| Reference price 2 | 27.33 | 10.99 | 9.940 | 5.300 | 5.300 | 5.300 |
| Announcement Date | 23/02/22 | 23/02/23 | 28/02/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 166.2 | 222.7 | 251.4 | 258.3 | 273.3 | 292.3 |
| EBITDA 1 | - | 55.99 | 63.75 | 74.45 | 82.74 | 91.36 | 104.2 |
| EBIT 1 | - | 53.19 | 60.51 | 68.8 | 77.25 | 86.04 | 97.3 |
| Operating Margin | - | 32.01% | 27.18% | 27.37% | 29.9% | 31.48% | 33.28% |
| Earnings before Tax (EBT) 1 | - | -60.58 | -39.44 | -308.2 | -32.29 | -19.66 | - |
| Net income 1 | -51.16 | -17.68 | -6.037 | -202.4 | -30.16 | -18.84 | -10.65 |
| Net margin | - | -10.64% | -2.71% | -80.5% | -11.68% | -6.89% | -3.64% |
| EPS 2 | -0.4000 | -0.1900 | -0.0600 | -1.790 | -0.2780 | -0.2533 | -0.3800 |
| Free Cash Flow 1 | - | 18.48 | 27.25 | 38.21 | 71.01 | 84.55 | 104 |
| FCF margin | - | 11.12% | 12.24% | 15.2% | 27.49% | 30.94% | 35.58% |
| FCF Conversion (EBITDA) | - | 33.01% | 42.75% | 51.32% | 85.82% | 92.55% | 99.84% |
| FCF Conversion (Net income) | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Announcement Date | 28/05/21 | 23/02/22 | 23/02/23 | 28/02/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 46.31 | 50.12 | 54.55 | 57.38 | 60.6 | 59.2 | 60.96 | 65.32 | 65.93 | 63.48 | 62.7 | 65.35 | 66.8 | 66.69 | 65.83 |
| EBITDA 1 | 13.1 | 14.04 | 16.27 | 16.39 | 17.05 | 15.67 | 17.24 | 21.74 | 19.8 | 20.02 | 19.2 | 21.55 | 22.01 | 20.65 | 21.02 |
| EBIT 1 | 12.27 | 13.24 | 15.26 | 15.67 | 16.33 | 14.09 | 16.02 | 20.38 | 18.31 | 18.55 | 17.79 | 20.32 | 20.58 | 20.02 | 20 |
| Operating Margin | 26.49% | 26.42% | 27.98% | 27.31% | 26.95% | 23.8% | 26.28% | 31.2% | 27.77% | 29.22% | 28.38% | 31.09% | 30.81% | 30.02% | 30.39% |
| Earnings before Tax (EBT) 1 | -14.09 | -12.97 | -9.792 | -6.369 | -10.31 | -16.31 | -13.09 | -266.2 | -12.19 | -13.5 | -7.71 | -5.959 | -5.148 | -5.478 | -5.485 |
| Net income 1 | -9.699 | -8.624 | -5.15 | -2.689 | 10.43 | -11.82 | -8.566 | -171.5 | -10.23 | -12.72 | -7.972 | -6.173 | -5.39 | -5.604 | -5.61 |
| Net margin | -20.94% | -17.21% | -9.44% | -4.69% | 17.2% | -19.96% | -14.05% | -262.57% | -15.52% | -20.03% | -12.72% | -9.45% | -8.07% | -8.4% | -8.52% |
| EPS 2 | -0.1000 | -0.0900 | -0.0500 | -0.0300 | 0.0700 | -0.1100 | -0.0800 | -1.500 | -0.0900 | -0.0800 | -0.0700 | -0.0580 | -0.0560 | -0.0500 | -0.0450 |
| Dividend per Share 2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 23/02/22 | 05/05/22 | 04/08/22 | 03/11/22 | 23/02/23 | 04/05/23 | 14/08/23 | 02/11/23 | 28/02/24 | 07/05/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - |
| Net Cash position 1 | - | 117 | 67.5 | 51.8 | 55.2 | 108 | 144 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow 1 | - | 18.5 | 27.3 | 38.2 | 71 | 84.6 | 104 |
| ROE (net income / shareholders' equity) | - | 1.29% | 3.94% | 5.16% | 6.18% | 6.83% | 7.65% |
| ROA (Net income/ Total Assets) | - | -0.92% | -0.28% | -10.3% | 3.18% | 3.37% | 3.67% |
| Assets 1 | - | 1,921 | 2,119 | 1,974 | -947.9 | -559.6 | -290.5 |
| Book Value Per Share 2 | - | 5.730 | 6.120 | 7.640 | 6.780 | 6.250 | 6.340 |
| Cash Flow per Share 2 | - | 0.2700 | 0.3500 | 0.3700 | 0.6500 | 0.5300 | 0.6300 |
| Capex 1 | - | 6.73 | 8.33 | 2.98 | 4.22 | 4.57 | 5 |
| Capex / Sales | - | 4.05% | 3.74% | 1.18% | 1.63% | 1.67% | 1.71% |
| Announcement Date | 28/05/21 | 23/02/22 | 23/02/23 | 28/02/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
5.3
USD
Average target price
8.45
USD
Spread / Average Target
+59.43%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -46.68% | 625M | |
| +20.24% | 3,361B | |
| +16.24% | 91.7B | |
| +13.57% | 84.81B | |
| +40.36% | 53.67B | |
| -19.57% | 50B | |
| +35.78% | 47.79B | |
| -27.83% | 44.68B | |
| +84.94% | 43.02B | |
| -2.12% | 27.57B |
- Stock Market
- Equities
- DH Stock
- Financials Definitive Healthcare Corp.
